Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-12-2026-11_15_25-AM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Eisai claims UK grant to expand manufacturing site
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

pharminent June 15, 2026 (Last updated: June 15, 2026)

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Key pipeline drug for Lundbeck delivers in Cushing syndrome

Related Stories

  • Manufacturing

Cellares and TScan to assess automated manufacturing of TSC-101 therapy

pharminent June 4, 2026
  • Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb

pharminent June 2, 2026
  • Manufacturing

FUJIFILM opens new iPSC facility in Madison, US

pharminent May 21, 2026

You May Have Missed

  • Manufacturing

Eisai claims UK grant to expand manufacturing site

pharminent June 15, 2026
  • Clinical Data

Key pipeline drug for Lundbeck delivers in Cushing syndrome

pharminent June 15, 2026
  • Clinical Data

Rhythm’s obesity drug scores ‘better than expected’ weight loss in rare genetic disease

pharminent June 15, 2026
  • Clinical Data

Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy

pharminent June 15, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.